Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0000902664-18-000893
Filing Date
2018-02-12
Accepted
2018-02-12 16:25:36
Documents
1

Document Format Files

Seq Description Document Type Size
1 JAGUAR HEALTH, INC. p18-0506sc13d.htm SC 13D 81970
  Complete submission text file 0000902664-18-000893.txt   83618
Mailing Address 201 MISSION STREET, SUITE 2375 SAN FRANCISCO CA 94105
Business Address 201 MISSION STREET, SUITE 2375 SAN FRANCISCO CA 94105 415-896-5081
Jaguar Health, Inc. (Subject) CIK: 0001585608 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-88872 | Film No.: 18596742
SIC: 2834 Pharmaceutical Preparations

Mailing Address PO BOX 282, REGENCY COURT GLATEGNY ESPLANADE ST PETER PORT Y7 GY1 3RH
Business Address PO BOX 282, REGENCY COURT GLATEGNY ESPLANADE ST PETER PORT Y7 GY1 3RH 44 (0)1481 723450
Nantucket Investments Ltd (Filed by) CIK: 0001714148 (see all company filings)

EIN.: 000000000 | State of Incorp.: Y7 | Fiscal Year End: 1231
Type: SC 13D